Kentucky Retirement Systems Insurance Trust Fund lessened its stake in MetLife, Inc. (NYSE:MET – Free Report) by 9.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,417 shares of the financial services provider’s stock after selling 1,850 shares during the period. Kentucky Retirement Systems Insurance Trust Fund’s holdings in MetLife were worth $1,437,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. MeadowBrook Investment Advisors LLC raised its position in shares of MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. increased its position in MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC raised its holdings in MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 277 shares during the last quarter. Fortitude Family Office LLC lifted its position in MetLife by 177.3% during the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 266 shares during the period. Finally, Coastline Trust Co bought a new position in shares of MetLife in the 3rd quarter valued at about $35,000. Institutional investors and hedge funds own 89.81% of the company’s stock.
MetLife Trading Up 0.9 %
Shares of NYSE:MET opened at $83.33 on Friday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The firm has a market cap of $57.70 billion, a price-to-earnings ratio of 16.80, a PEG ratio of 0.76 and a beta of 1.05. MetLife, Inc. has a 12 month low of $61.61 and a 12 month high of $86.94. The company’s fifty day simple moving average is $81.60 and its 200 day simple moving average is $75.59.
MetLife Dividend Announcement
Wall Street Analyst Weigh In
MET has been the topic of several analyst reports. Morgan Stanley cut their price objective on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a report on Monday, August 19th. Wells Fargo & Company increased their price target on MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Bank of America decreased their price objective on MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a research note on Thursday, August 1st. Citigroup increased their target price on MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a research note on Tuesday, July 23rd. Finally, Barclays reduced their target price on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Thursday, October 31st. Fourteen equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $88.46.
View Our Latest Research Report on MET
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- What Does Downgrade Mean in Investing?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- What is the S&P 500 and How It is Distinct from Other Indexes
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Time to Load Up on Home Builders?
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.